Corentec is a premier manufacturer of artificial joints established by an eminent doctor who specializes in the field. Renowned for its R&D team and clinical research, Corentec produces various artificial joint products including spinal fixation devices, hip joints and knee joints. Stonebridge Capital contributed to Corentec’s performance by advising the company to customize surgical tools for individual surgeons who treat joint patients, which led to a significant growth in market share.

Since Stonebridge’s investment in 2010, Corentec’s sales grew at 75% CAGR based on its established technology.

In 2011 when Corentec was experiencing financial difficulties, Stonebridge alone saw a potential in Corentec and executed a follow-up common stock investment. By advising Corentec on the technical evaluation IPO policy, Stonebridge also led the company’s listing on the KOSDAQ, thereby solving its financial problems and giving it a new growth momentum.